TXG — 10x Genomics, Inc.
—
Nasdaq ·
Unknown ·
Unknown ·
CIK 1770787 ·
Last close
$80.65
Market Cap
$9.70B
52W High
$102.81
52W Low
$11.16
ADV30
3,472,209
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 150,843,000 | 106,178,000 | -17,046,000 | -13,470,000 | 1,015,759,000 | 490,285,000 | 201,435,000 |
| Dec 2025 | 166,030,000 | 113,045,000 | -19,541,000 | -16,252,000 | 1,041,365,000 | 473,966,000 | 245,039,000 |
| Sep 2025 | 149,002,000 | 100,307,000 | -32,242,000 | -27,472,000 | 1,027,361,000 | 432,508,000 | 242,241,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$127,819,000
Investing CF
$-12,856,000
Financing CF
$-2,036,000
CapEx
$-5,639,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.59
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,524,061,000
Inventory
$53,487,000
Receivables
$56,137,000
ST Investments
$49,563,000
EBIT TTM
$39,149,000
Pretax Income TTM
$-19,248,000
Interest Exp TTM
$3,000
Analysts
13
Yahoo Snapshot (yfinance, live)
Total Revenue
$616,910,976
EBITDA
$-41,201,000
Free Cash Flow
$179,656,000
Enterprise Value
$8,463,434,240
Total Cash
$552,033,024
Total Debt
$78,796,000
Shares Out
120,212,296
Trailing EPS
$-0.60
Book Value
$6.31
ROE
-9.4%
ROA
-5.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 642,823,000 | -110,885,000 | -43,544,000 | 1,041,365,000 | 245,039,000 | 796,326,000 | 136,050,000 |
| Dec 2024 | 610,785,000 | -194,559,000 | -182,627,000 | 918,636,000 | 208,502,000 | 710,134,000 | 6,664,000 |
| Dec 2023 | 618,727,000 | -204,349,000 | -255,099,000 | 965,143,000 | 224,100,000 | 741,043,000 | -15,197,000 |
| Dec 2022 | 516,409,000 | -167,944,000 | -166,000,000 | 1,028,980,000 | 223,237,000 | 805,743,000 | -33,606,000 |
TTM Snapshot
Revenues TTM
$638,783,000
NetIncome TTM
$-22,656,000
OpCashFlow TTM
—
Assets (Latest)
$1,015,759,000
Forward EPS
$0.20
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| DRS | Leonardo DRS, Inc. | $9.67B | $36.24 | — |
| DLAKY | DEUTSCHE LUFTHANSA A G /FI | $9.80B | $8.15 | — |
| PSORF | PEARSON PLC | $9.56B | $15.91 | — |
| SOAGY | Sartorius AG/ADR | $9.87B | $56.73 | — |
| WMS | ADVANCED DRAINAGE SYSTEMS, INC. | $9.49B | $125.79 | — |
News headlines (Yahoo Finance, 1h cache)
Why Are 10x Genomics (TXG) Shares Soaring Today
2026-10-10 00:27 · Yahoo
Is 10x Genomics (TXG) Using Its Fred Hutch Oncology Alliance To Redefine Its Clinical Moat?
2026-10-09 09:17 · Yahoo
10x Genomics & Fred Hutch Join Forces on Cancer Biomarker Research
2026-10-08 13:21 · Yahoo
10x Genomics Announces New Collaboration to Advance Single Cell and Spatial Applications Across Solid Tumors and Blood Cancers
2026-10-07 13:00 · Yahoo
Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies – Unloads $18M Worth Of TWST Shares
2026-10-06 12:16 · Yahoo
10x Genomics (TXG) Starts Atera Shipments And Sentira, Is The Upside Already Priced In?
2026-10-05 20:06 · Yahoo
Cathie Wood’s ARKG Is Crushing Her Other ETFs: 2 Biotech Bets Have Surged Nearly 6X This Year
2026-10-05 06:44 · Yahoo
10x Genomics Begins Atera Shipments as Spatial Biology Demand Rises
2026-09-30 15:07 · Yahoo
10x Genomics Begins Global Shipments of Atera, Putting Unprecedented Spatial Biology Capabilities in Researchers' Hands
2026-09-29 13:00 · Yahoo
Q2 Rundown: 10x Genomics (NASDAQ:TXG) Vs Other Life Sciences Tools & Services Stocks
2026-09-22 13:33 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.